Epstein-Barr Virus and the Wnt Pathway
Author Information
Author(s): Webb Natasha, Connolly Geoff, Tellam Judy, Yap Alpha S., Khanna Rajiv
Primary Institution: Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia
Hypothesis
Does the expression of LMP1 affect the regulation of the Wnt pathway in virus-infected cells?
Conclusion
The study found that LMP1 does not influence the expression of various mediators of the Wnt pathway.
Supporting Evidence
- Previous studies suggested LMP1 could repress E-cadherin expression, but this study found no such effect.
- Transient and stable expression of LMP1 did not impair E-cadherin and β-catenin expression.
- Immunoblot analysis showed comparable levels of Wnt pathway mediators in LMP1 and control cells.
Takeaway
The researchers looked at how a virus protein called LMP1 affects certain cell functions, but they found it doesn't change how some important proteins work together.
Methodology
The study used human epithelial and keratinocyte cell lines to express different sequence variants of LMP1 and assessed its effect on E-cadherin and β-catenin interaction/function.
Limitations
The study does not refute a potential role of other EBV proteins in activating β-catenin.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website